These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38843485)

  • 21. Letter to the Editor: Retreatment Decision for Hepatitis B Flare in HBeAg-Negative Chronic Hepatitis B.
    Kumar K; Dixit I
    Hepatology; 2021 May; 73(5):2081-2082. PubMed ID: 33030272
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues.
    Jang TY
    Aliment Pharmacol Ther; 2023 Mar; 57(5):587-588. PubMed ID: 36786461
    [No Abstract]   [Full Text] [Related]  

  • 23. [Liver histological status and clinic outcome in HBeAg-negative chronic hepatitis B with low viral load].
    Deng DL; Jiang JN; Su MH; Wang RM; Zang WW; Ling XZ; Wei HL; Liang XS; Zhou HK; He WM; Guo RS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):1013-1017. PubMed ID: 34865348
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter: improved alanine aminotransferase level in non-cirrhotic and low-viral load chronic hepatitis B patients treated with nucleotide/nucleoside analogues -authors' reply.
    Huang R; Wang J; Yan X; Zhu C; Wu C
    Aliment Pharmacol Ther; 2023 Mar; 57(5):589-590. PubMed ID: 36786453
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result.
    Cai S; Yu T; Jiang Y; Zhang Y; Lv F; Peng J
    Clin Exp Med; 2016 Aug; 16(3):429-36. PubMed ID: 26164128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter to the Editor: LO2, a misidentified cell line: Some data should be interpreted with caution.
    Weiskirchen R
    Hepatology; 2023 Apr; 77(4):E66. PubMed ID: 36040018
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter to the editor: Hepatitis B virus genotype: A significant risk factor in determining which patients with chronic hepatitis B virus infection should undergo surveillance for hepatocellular carcinoma: The hepatitis B Alaska study.
    Kumar A; Rajani D; Kumar S
    Hepatology; 2022 Sep; 76(3):E63-E64. PubMed ID: 35478185
    [No Abstract]   [Full Text] [Related]  

  • 28. Early hepatitis B viral DNA clearance predicts treatment response at week 96.
    Fu XY; Tan DM; Liu CM; Gu B; Hu LH; Peng ZT; Chen B; Xie YL; Gong HY; Hu XX; Yao LH; Xu XP; Fu ZY; He LQ; Li SH; Long YZ; Li DH; Gu JL; Peng SF
    World J Gastroenterol; 2017 Apr; 23(16):2978-2986. PubMed ID: 28522916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Viral load survey from geographical areas within Argentina with high hepatitis B virus prevalence].
    Amegeiras B; González JE; Jotimliansky L; Zingoni C; Vulcano C
    Acta Gastroenterol Latinoam; 2013 Mar; 43(1):16-21. PubMed ID: 23650829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load.
    Peleg N; Issachar A; Sneh Arbib O; Cohen-Naftaly M; Braun M; Leshno M; Barsheshet A; Shlomai A
    JHEP Rep; 2019 May; 1(1):9-16. PubMed ID: 32039349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.
    ter Borg MJ; Hansen BE; Bigot G; Haagmans BL; Janssen HL
    J Clin Virol; 2008 Jun; 42(2):160-4. PubMed ID: 18359663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter to the Editor: Age at Hepatitis B e Antigen Seroconversion and Other Factors for Outcomes of Chronic Hepatitis B.
    Chu CM; Liaw YF
    Hepatology; 2019 Jun; 69(6):2711. PubMed ID: 30014494
    [No Abstract]   [Full Text] [Related]  

  • 33. MicroRNA levels in patients with chronic hepatitis B virus and HIV coinfection in a high-prevalence setting; KwaZulu-Natal, South Africa.
    Mthethwa L; Parboosing R; Msomi N
    BMC Infect Dis; 2024 Aug; 24(1):833. PubMed ID: 39148016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of mRNA expression of toll-like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Kataki K; Borthakur P; Kumari N; Deka M; Kataki AC; Medhi S
    J Med Virol; 2017 Jun; 89(6):1008-1014. PubMed ID: 27769109
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Park J; Yoo J; Jang J; Lee GD; Cho B; Oh EJ
    Ann Clin Lab Sci; 2022 Jul; 52(4):684-685. PubMed ID: 36197782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis.
    Mealing S; Ghement I; Hawkins N; Scott DA; Lescrauwaet B; Watt M; Thursz M; Lampertico P; Mantovani L; Morais E; Bregman B; Cucherat M
    Syst Rev; 2014 Mar; 3():21. PubMed ID: 24602249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does Silybum marianum play a role in the treatment of chronic hepatitis C?
    Torres M; Rodríguez-Serrano F; Rosario DJ; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):69-74. PubMed ID: 16929590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediation effect of hepatitis B and C on mortality.
    Huang YT; Freeman JR; Yang HI; Liu J; Lee MH; Chen CJ
    Eur J Epidemiol; 2016 Jun; 31(6):625-33. PubMed ID: 26792787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical effect of entecavir versus tenofovir in treatment of HBeAg-positive chronic hepatitis B patients with a high viral load: a comparative analysis].
    Shi H; Li XY; Zhu JY; Lin CS; Zhang Y
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):721-725. PubMed ID: 29108198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.